Clinical application of enoxaparin. - Wikidata - wikimedia - TriplyDB

Clinical application of enoxaparin.

Clinical application of enoxaparin.

http://www.wikidata.org/entity/Q33360866

about

Enoxaparin-induced reversible pancytopenia.

P2860

Q46970478-95B9DF24-D44B-44C5-A337-EE48455FE300

P2860

Clinical application of enoxaparin.

http://www.wikidata.org/entity/Q33360866

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Clinical application of enoxaparin.

@ast

Clinical application of enoxaparin.

@en

type

label

Clinical application of enoxaparin.

@ast

Clinical application of enoxaparin.

@en

prefLabel

Clinical application of enoxaparin.

@ast

Clinical application of enoxaparin.

@en

P1433

Q33360866-2BD910F3-A9B0-4D13-BA85-34D65C7435D5

P1476

Q33360866-A7D180B8-A23A-4646-AF97-69140A072F8B

P2093

Q33360866-98854329-701E-48AF-ACC9-9702C0EF7593

P2860

Q33360866-0CFA5BB9-D15E-49D1-9C24-ABB28A0D3AFF

Q33360866-0D9F5FEF-7609-4A79-944C-6B59853CD7B0

Q33360866-106A173B-0501-4FB9-A023-D158F5A58D38

Q33360866-21DB5C90-9D65-4851-A303-722BCE10B38C

Q33360866-21FCBB33-B4C8-4424-9E57-71CE98C02B88

Q33360866-2B3DA496-C815-4CBB-AD79-BDEBC07137DB

Q33360866-2FAC08CF-0022-4043-B4BE-56B491FD0730

Q33360866-40316CE4-C918-4633-837E-01BBD99140A5

Q33360866-4258590C-3EEB-4276-A3ED-006EF41C0D14

Q33360866-49013DA8-2417-49FD-BA01-945A426A0B5C

P304

Q33360866-A8557CB4-6897-4FCE-8A79-8722F408CA25

P31

Q33360866-DCC474B8-7A44-4D33-8D41-A56C1D669387

P356

Q33360866-8071583A-65CE-4313-A887-DA6FE1592248

P433

Q33360866-4A6C0BF1-7BA9-430A-A1CB-1B4830360C0C

P478

Q33360866-B91CEEAF-0292-4CED-97BE-A54AA77C5A62

P577

Q33360866-3052C280-8495-48D9-9BA5-7C8A086ADE04

P698

Q33360866-18171BB5-7FC0-4607-8A06-2B73D7ACF435

P356

14779072.2.3.321

P1433

Expert Review of Cardiovascular Therapy

P1476

Clinical application of enoxaparin.

@en

P2093

Thomas Hofmann

http://www.w3.org/2001/XMLSchema#string

P2860

Randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: second trial of Heparin and Aspirin Reperfusion Therapy (HART II)

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.

An update on heparins at the beginning of the new millennium.

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.

A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.

Low molecular weight versus unfractionated heparin. A clinical and economic appraisal.

Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery.

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology.

Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Anticoagulation of pregnant women with mechanical heart valves.

P304

321-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14779072.2.3.321

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15151480

http://www.w3.org/2001/XMLSchema#string